Detalhe da pesquisa
1.
Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
Trials;
22(1): 9, 2021 Jan 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33407777
2.
Evaluation of convalescent plasma versus standard of care for the treatment of COVID-19 in hospitalized patients: study protocol for a phase 2 randomized, open-label, controlled, multicenter trial.
Trials;
22(1): 70, 2021 Jan 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33472681